Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study

The goal of treatment in patients with pulmonary arterial hypertension is to achieve a low risk status, indicating a favorable long-term outcome. The REPLACE study investigated the efficacy of switching to riociguat in patients with pulmonary arterial hypertension and an insufficient response to pho...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pulm Circ
Main Authors: Simonneau, Gérald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Rosenkranz, Stephan, Grünig, Ekkehard, White, Jim, McLaughlin, Vallerie V., Langleben, David, Meier, Christian, Busse, Dennis, Kleinjung, Frank, Benza, Raymond L.
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2020
Assuntos:
Original Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734510/
https://ncbi.nlm.nih.gov/pubmed/33354316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020973124
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares